Kavanaugh, Arthur
Singh, Rakesh
Karki, Chitra
Etzel, Carol J.
Kremer, Joel M.
Greenberg, Jeffrey D.
Griffith, Jenny
Funding for this research was provided by:
AbbVie
Article History
Received: 7 March 2018
Revised: 2 May 2018
Accepted: 4 May 2018
First Online: 4 June 2018
Compliance with ethical standards
:
: All participating investigators were required to obtain full board approval for conducting non-interventional research involving human subjects with a limited dataset. Sponsor approval and continuing review was obtained through a central IRB (New England Independent Review board, NEIRB No. 02-021). For academic investigative sites that did not receive a waiver to use the central IRB, full board approval was obtained from the respective governing IRBs and documentation of approval was submitted to the Sponsor prior to initiating any study procedures.
: All registry subjects were required to provide written informed consent and authorization prior to participating.
: Dr. Kavanaugh has served as a consultant to AbbVie and has conducted clinical research sponsored by AbbVie. Chitra Karki and Carol Etzel are Corrona employees. Dr. Kremer is a Corrona employee and has provided consulting services and received research grant support from AbbVie. Dr. Greenberg is an employee and shareholder of Corrona. Rakesh Singh and Jenny Griffith are AbbVie employees and own company stock. Editorial assistance was provided by Madhuri Vemuri and Steve Dawber of Fishawack Communications Ltd. AbbVie provided funding to Fishawack for this work.